Clinical Trial Detail

NCT ID NCT02831933
Title Trial of Stereotactic Body Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma (ENSIGN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eric Bernicker, MD
Indications

lung non-small cell carcinoma

Therapies

AdV-tk + Nivolumab

Age Groups: senior adult

No variant requirements are available.